N-(4-Amino-1,2,5-oxadiazol-3-yl)acetamide,
140706-47-4,
N-(4-Amino-furazan-3-yl)-acetamide,
GVZQUWHSBVLLCC-UHFFFAOYSA-N,
N-(4-Amino-furazan-3-yl)acetamide,
ZERO/005444,
AC1LBJ4V,
AC1Q5O1C,
3-acetamido-4-amino-furazan,
acetamide, n-(4-amino-1,2,5-oxadiazol-3-yl)-,
Oprea1_843242,
SCHEMBL1457764,
furazanamine, 4-(acetylamino)-,
CTK6A1144,
Furazan, 3-acetylamino-4-amino-,
BB_SC-01301,
ZINC1095780,
ZX-CM002815,
4176AD,
BBL012034,
FCH835756,
MFCD02334723,
SBB000085,
STK729610,
AKOS000299244,
Acetamide, N-(4-amino-3-furazanyl)-,
MCULE-7582347603,
RTR-045486,
3-Amino-4-acetylamino-1,2,5-oxadiazole,
AJ-25040,
BAS 16576925,
DA-18678,
ST018445,
ZB016027,
TR-045486,
FT-0709377,
W-9408,
N-(4-Amino-1,2,5-oxadiazol-3-yl)acetamide #,
4004454-25G,
4004454-50G,
F3110-1015,
4004454-100G,
N-(4-Amino-1,2,5-oxadiazol-3-yl)acetamide, AldrichCPR,
C4H6N4O2,
AR-1H6218,
CID536687,
5-Bromo-2-methylimidazo[1,2-a]pyridine,
14119-15-4,